AI in Computational Pathology: Grading Tumor Biopsies

Computational pathology leverages artificial intelligence to transform how tumor biopsies are analyzed and graded from whole-slide microscopic images. This article provides a comprehensive overview of the digital pathology workflow, beginning with the digitization of physical tissue samples into massive image files, followed by data preprocessing, and concluding with how deep learning models extract cellular features to determine tumor severity with high accuracy and speed.

Digitizing the Biopsy: Whole-Slide Imaging

Before artificial intelligence can analyze a tumor, a physical biopsy must be converted into a digital format. Pathologists place thin slices of stained tissue—typically using Hematoxylin and Eosin (H&E) to highlight cellular structures—onto glass slides. High-resolution slide scanners then capture these samples at microscopic magnifications, creating Whole-Slide Images (WSIs). These gigapixel files contain billions of pixels, preserving the intricate cellular architecture required for accurate cancer grading.

Preprocessing Gigapixel Images

Because WSIs are too large to be processed all at once by standard computer hardware, AI systems must break the data down into manageable pieces. The preprocessing stage involves several critical steps:

  • Tissue Detection: Algorithms separate the actual tissue sample from the blank background of the glass slide to save computational power.
  • Tiling: The tissue region is divided into thousands of smaller, uniform square patches (tiles), often 256x256 or 512x512 pixels in size.
  • Color Normalization: Because different laboratories use varying batches of chemical stains and different scanners, AI applies color normalization to standardize the visual appearance of the tiles.

Feature Extraction with Deep Learning

Once the image is tiled, deep learning architectures—primarily Convolutional Neural Networks (CNNs) and Vision Transformers (ViTs)—analyze the individual patches. The AI scans these tiles to identify and quantify specific histopathological features that indicate cancer progression:

  • Cellular Morphology: The AI measures the size, shape, and irregularity of individual cancer cell nuclei.
  • Mitotic Count: The algorithm detects and counts cells that are actively dividing, which indicates how fast the tumor is growing.
  • Glandular Architecture: In cancers like prostate or breast cancer, the AI evaluates how much the tumor cells have lost their normal, organized tissue structure.

Aggregating Data for the Final Tumor Grade

A single biopsy slide may contain both healthy tissue and varying degrees of cancerous tissue. To assign an overall grade to the entire slide without requiring pathologists to manually label every single tile, computational pathology relies on Weakly Supervised Learning, specifically Multiple Instance Learning (MIL).

The MIL algorithm reviews the predictions from all the individual tiles, weighs their importance, and aggregates the data to generate a slide-level diagnosis. For example, in prostate cancer, the AI identifies the primary and secondary patterns of cell growth across the tiles to automatically calculate a Gleason score.

Clinical Impact and Benefits

Integrating AI into the tumor grading process addresses several bottlenecks in traditional pathology. Human grading is inherently subjective; two pathologists might assign a slightly different grade to the same borderline biopsy. AI provides standardized, reproducible measurements every time. Furthermore, AI acts as a rapid triage tool, flagging high-grade, aggressive tumors so pathologists can prioritize critical cases, ultimately accelerating the time to treatment for patients.